|
De Boer I H, Gorodetskaya I, Young B. The Severity of Secondary Hyperparathyroidism in Chronic Renal Insufficiency is GFR-Dependent, Race-Dependent, andAssociated with Cardiovascular Disease [J]. Journal of the American Society of Nephrology, 2002, (11):2762.
|
|
Rodriguez M, Nemeth E, Martin D. The calcium-sensing receptor:a key factor in the pathogenesis of secondary hyperparathyroidism [J]. American Journal of Physiology-Renal Physiology, 2005(2):253.
|
|
Tokumoto M, TaniguchiM, Matsuo D. Parathyroid cell growth in patients with advanced secondary hyperparathyroidism:vitamin Drecep tor, calcium sensing recep tor, and cell cycle regulating factors [J]. Therapeutic Apheresis and Dialysis, 2005(1):27.doi: 10.1111/j.1744-9987.2005.00302.x.
|
|
Hruska K A, Steven 1, Teitelbaum. Renal osteodystrophy [J]. the New England Journal of Medicine, 1995(3):166.
|
|
Raggi P, Boulay A, Chasan-Taber S. Cardiac calcification in adult hemodialysis patients:A link between ESRD and cardiovascular disease [J]. Journal of the American College of Cardiology, 2002(4):695.doi: 10.1016/S0735-1097(01)01781-8.
|
|
印荻, 章旭. 慢性肾脏病患者的颈动脉粥样硬化及心脏瓣膜钙化 [J]. 临床肾脏病杂志, 2009(6):285.
|
|
Drueke T B, Eckardt K U. Role of secondary hyperparathyroidism in erythropoietin resistance of chronic renal failure patients [J]. Nephrology Dialysis Transplantation, 2002(5):28.
|
|
Fukuda N, Tanaka H, Tominaga Y. Decreased 1, 25-dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronicuremic patients [J]. Journal of Clinical Investigation, 1993.1436.doi: 10.1172/JCI116720.
|
|
Barros Gueiros J E, Chammas M C, Gerhard R. Percutaneous ethanol(PEIT) and calcitrol(PCIT) injection therapy are ineffective in treating severe secondary hyperparathyroidism [J]. Nephrology Dialysis Transplantation, 2004(3):657.doi: 10.1093/ndt/gfg586.
|
|
TanakaM, ItohK, MatsushitaK. Efficacy of percutaneous ethanol injection therapy for secondary hyperparathyroidism in pationts on hemodialysis as evaluated by parathyroid hormone levels according to K/DOQI guidelines [J]. Therapeutic Apheresis and Dialysis, 2005(1):48.doi: 10.1111/j.1774-9987.2005.00214.x.
|
|
Tanaka R, Kakuta T, Fujisaki T. long-term (3years) prognosis of parathyroid function in chronic dialysis patients after percutaneous sthanol injection therapy guided by colour Doppler ultrasonography [J]. Nephrology Dialysis Transplantation, 2003.58.doi: 10.1093/ndt/gfg1015.
|
下载:
苏公网安备 32100302010246号
